In South Africa, tuberculosis is mainly diagnosed and treated in the public healthcare system. On paper, the private sector should also be able to deal with it, but in reality, TB care in this sector is often fragmented and confusing. Elri Voigt asks local experts why things work like this and what can be done about it.
South Africa’s HIV programme is under profound pressure. The answer should not be to make people living with HIV work harder to stay on treatment, but to remove unnecessary visits and use scarce clinical capacity where it is needed most, argue Dr Anna Grimsrud and Lynne Wilkinson.
In recent decades, we’ve seen massive advances against several types of cancer. In a still unfolding example, South Africa’s massive HPV vaccination campaign is set to slash cervical cancer rates in the coming decades. Biénne Huisman unpacks the details in part 3 of a Daily Maverick and Spotlight special series on cancer in South Africa.
Imagine you have been taking a medicine for years. Then one day you are told at the pharmacy that supplies have run out. In his latest Spotlight column, Dr Andy Gray zooms in on how governments can monitor and plan for such shortages.
It isn’t always easy to know what to believe when it comes to cancer. In part 2 of a Daily Maverick and Spotlight special series on cancer, Biénne Huisman asks whether cancer cases are on the increase in South Africa, and why. On the way, she visits academic corridors and a Limpopo citrus orchard, all while trying to make sense of the available data.
All medicines and treatments have to go through lengthy safety and efficacy testing, but this is particularly tricky – and often delayed – for one important age group. Elna Schütz explores the complexities of conducting clinical trials involving babies, and why those complexities are worth grappling with.
Two women, two breast cancer journeys. In the first article of a new Daily Maverick and Spotlight special series on cancer in South Africa, Biénne Huisman speaks with rugby referee Aimee Barrett-Theron and cancer warrior Joyce Witbooi, who helps women navigate Cape Town’s public health system.
Many people who report with TB symptoms at South Africa’s public sector clinics do not receive TB tests. Testing more of these people is one of the most effective things we can do to reduce rates of TB disease and death, according to a major new modelling study. Marcus Low reports.
Precious Matsoso tells Biénne Huisman how, over three decades, she helped shape some of the most consequential health policy negotiations in South Africa and in global governance. She also shares memories about her Soweto childhood filled with music, science, and political uprisings.
Aspen Pharmacare has announced that it will not be manufacturing the lenacapavir HIV prevention injection, and that it will instead focus on producing alimatravir, an experimental HIV prevention pill. Catherine Tomlinson explores the reasoning behind Aspen’s decision and assesses what it all means for local pharmaceutical production.
A crucial hotline run for nearly 20 years from the slopes of Devil’s Peak in Cape Town for healthcare workers anywhere in South Africa, from the country’s busiest urban hospitals to far flung resource strained rural clinics, has been suspended due to a lack of funding.
One of the top killers of people living with HIV in South Africa is a fungal infection caused by spores found all around us. In this Spotlight special briefing, Elri Voigt unpacks what we know about this dangerous disease called cryptococcal meningitis, why it remains so deadly, and what we can do about it.
